Immunefi

Web3 bug bounty and security platform connecting whitehat researchers with crypto projects to disclose vulnerabilities and earn payouts.

Visit Website ↗ + Add to Compare Claim This Company

68/100Incremental Innovator

Overview

Immunefi operates a bug bounty marketplace focused on blockchain protocols, DeFi applications and crypto infrastructure. Projects publish scoped programs with reward tiers tied to severity and funds at risk, and independent researchers submit vulnerabilities through the platform.

The company takes a commission on payouts and provides triage and mediation. Founded in December 2020 and headquartered in Singapore, it raised a $24 million Series A in September 2022 led by Framework Ventures.

Innovation Matrix Assessment

Innovation Velocity 7/10

Built web3-specific bounty tooling, severity systems and mediation early in the category; specifics of recent releases not independently reviewed.

Operational Value 7/10

Gives protocols a continuous, incentive-aligned vulnerability discovery channel; value is concentrated in the crypto sector.

Market Momentum 7/10

$24M Series A (Sept 2022) reported by The Block; broad adoption among major protocols, though latest funding data not confirmed.

Category Disruption 6/10

Adapts the bug bounty model to on-chain risk with payouts scaled to funds at risk, but remains a bounty platform variant.

Real-World Efficacy 7/10

Reported bounty payouts in the tens of millions of dollars (as of 2022 coverage) indicate real findings; totals are company-stated.

Enduring Relevance 7/10

Smart contract and web3 risk persists, though dependent on crypto market health.

Why CISOs Should Care

Web3 projects hold funds directly in code, so a pre-exploit disclosure channel with defined rewards reduces the chance of an irreversible loss.

What Makes It Different

Bounty size is scaled to the value at risk on-chain, and the platform specialises in web3 scoping and mediation rather than general web apps.

The Matrix Verdict

68/100 — INCREMENTAL INNOVATOR

Immunefi is a Meaningful Innovator in a narrow but important niche. Its adaptation of crowd-sourced testing to on-chain risk is well established, with credible funding, though its disruption beyond the web3 sector is limited and recent traction data is thin.

Editorial Note: Claims vs. Verified Findings

Payout totals and funds-saved figures come from the company via press coverage and are not independently audited. The Series A funding is reported by The Block.

Sources

Alternatives to Immunefi

80 /100

Synack Inc

A penetration-testing-as-a-service platform pairing a vetted researcher community with AI-driven attack surface discovery for continuous security validation.

Meaningful Innovator Threat & Vulnerability Management

80 /100

Horizon3.ai

Autonomous penetration testing company whose NodeZero platform self-attacks networks without persistent agents, aiming to replace annual manual pentests…

Meaningful Innovator Threat & Vulnerability Management

78 /100

Unknown Cyber Inc.

CISO Reviewed

Malware genomics platform using automated deep static analysis and code-lineage comparison to identify unseen malware, variants, and supply-chain…

Meaningful Innovator Threat & Vulnerability Management

77 /100

Cogent Security

Agentic AI platform that autonomously triages, investigates, and remediates vulnerabilities as a force multiplier for security teams.

Meaningful Innovator Threat & Vulnerability Management

77 /100

Airlock Digital

Application allowlisting (deny-by-default) platform that blocks unapproved executables, scripts, and processes to prevent ransomware and malware execution.

Meaningful Innovator Threat & Vulnerability Management

75 /100

Pentera

Automated security validation platform that safely runs real attack techniques against production environments to prove which exposures are…

Meaningful Innovator Threat & Vulnerability Management